introduct
previou
work
demonstr
system
orbit
fatderiv
stem
cell
ofsc
transplant
effect
amelior
lipopolysaccharid
lp
induc
extens
acut
lung
injuri
ali
vivo
mainli
paracrin
regul
macrophagemedi
cytokinestorm
studi
explor
molecular
mechan
ofsc
regul
macrophag
activ
cytokineinduc
fashion
method
lp
ngml
activ
macrophag
treat
condit
medium
ofsc
ofscscm
noncontact
cultur
ofsc
hour
potenc
ofsc
macrophag
prolifer
proinflamm
abil
determin
express
level
proinflammatori
cytokin
macrophag
induc
immunomodulatori
factor
ofsc
investig
deep
sequenc
analysi
well
interact
microrna
mirna
gene
immunomodul
ofsc
induc
activ
macrophag
predict
mirtar
transfect
mirna
inhibitor
ofsc
perform
realtim
rtpcr
transplant
ofsc
mice
lpsinduc
ali
confirm
vitro
vivo
mechan
result
paracrin
effect
ofsc
inhibit
macrophag
proinflammatori
cytokin
releas
potent
induct
macrophag
cell
cycl
arrest
ofscscm
suppress
lpsinduc
induc
nitric
oxid
synthetas
proinflammatori
cytokin
tumor
necrosi
factoralpha
interleukin
il
alpha
beta
express
macrophag
noncontact
cultur
lpsactiv
macrophag
effect
trigger
express
solubl
immunomodul
factor
ofsc
ie
receptor
antagonist
ra
indoleamin
solubl
tnf
receptor
type
ii
stnf
rii
mirtar
predict
identifi
critic
microrna
regul
multipl
immunemodul
factor
ofsc
respons
macrophag
baselin
level
high
ofsc
downregul
upon
cocultur
activ
macrophag
observ
inhibitor
transfect
ofsc
select
enhanc
ra
stnf
rii
express
addit
inhibit
ofsc
enhanc
antiinflammatori
abil
lpsinduc
ali
paracrin
effect
ofsc
inhibit
proinflammatori
abil
prolifer
macrophag
immunemodul
capac
ofsc
trigger
activ
macrophag
downregul
enhanc
ofsc
immunomodul
abil
upregul
ra
stnf
rii
express
acut
respiratori
distress
syndrom
account
major
mortal
acut
lung
inflamm
trigger
variou
pathogen
includ
atyp
infect
sever
acut
respiratori
syndrom
cytokin
stormmedi
extens
lung
injuri
ultim
pathomechan
acut
respiratori
distress
syndrom
sever
acut
respiratori
syndrom
addit
specif
antibiot
antivir
agent
steroid
treatment
plasma
exchang
therapeut
strategi
reduc
local
circul
inflammatori
cytokin
level
safe
effect
therapi
elimin
cytokin
storm
critic
patient
sinc
sever
steroidrel
plasmapheresisassoci
complic
may
occur
sever
ill
patient
mesenchym
stem
cell
msc
stem
cell
capac
allogen
transplant
without
match
human
leukocyt
antigen
type
due
low
immunogenec
except
differenti
abil
msc
immunomodul
power
therapeut
strategi
graft
versu
host
diseas
autoimmun
neurolog
diseas
system
lupu
nephriti
acut
lung
tissu
injuri
diabet
msc
achiev
immunomodul
effect
innat
adapt
immun
secret
critic
solubl
factor
andor
direct
contact
regul
immun
cell
procytokin
interferon
gamma
interleukin
il
tumor
necrosi
factor
alpha
stimul
immunomodulatori
abil
msc
transform
growth
factor
beta
hepatocyt
growth
factor
indoleamin
ido
prostaglandin
e
thought
induc
immunomodul
factor
secret
msc
upon
procytokin
stimul
target
cell
b
cell
natur
killer
cell
littl
known
effect
msc
macrophag
critic
player
innat
immun
respons
involv
almost
immunemedi
diseas
studi
report
msc
deriv
bone
marrow
gingiva
promot
gener
regulatori
macrophag
receptor
antagonist
produc
msc
serv
key
factor
inhibit
macrophagemedi
inflamm
acut
lung
injuri
ali
previou
work
demonstr
orbit
fatderiv
stem
cell
ofsc
msc
isol
human
orbit
fat
tissu
effect
modul
lipopolysaccharid
lp
induc
acut
lung
inflamm
therapeut
effect
ofsc
vivo
attribut
inhibit
macrophagemedi
inflammatori
respons
paracrin
effect
ofsc
contribut
major
therapeut
benefit
howev
circul
cytokin
profil
alter
ofsc
ident
alter
bone
marrowderiv
msc
mice
ali
studi
investig
molecular
mechan
ofsc
macrophag
regul
paracrin
effect
lpsactiv
macrophag
treat
condit
medium
ofsc
ofscscm
noncontact
cultur
ofsc
chang
macrophag
ofsc
well
role
microrna
mirna
ofsc
regul
solubl
immunomodulatori
factor
induc
cytokin
elucid
isol
cultur
orbit
fatderiv
stem
cell
isol
cultur
ofsc
perform
describ
previous
sampl
remov
written
inform
consent
subject
studi
approv
institut
review
board
taipei
medic
universitywan
fang
hospit
brief
redund
orbit
fat
tissu
remov
intraorbit
caviti
adipos
tissu
fragment
digest
filter
centrifug
fluid
cell
result
pellet
plate
tissu
cultur
flask
bd
bioscienc
franklin
lake
nj
usa
maintain
mesen
pro
medium
invitrogen
carlsbad
ca
usa
surfac
phenotyp
ofsc
posit
msc
marker
neg
hematopoiet
marker
trilineag
differenti
abil
cell
check
previous
mous
macrophag
cell
line
obtain
american
type
cultur
collect
livingston
mt
usa
cell
maintain
dulbecco
modifi
eagl
medium
dmem
ham
nutrient
mixtur
contain
fetal
calf
serum
uml
penicillin
g
streptomycin
humidifi
incub
macrophageorbit
fatderiv
stem
cell
cocultur
studi
macrophag
incub
serumfre
medium
dmemham
medium
starvat
cocultur
ofsc
treat
ofscscm
ofsc
maintain
low
serum
medium
iscov
modifi
dulbecco
media
imdm
contain
fetal
bovin
serum
starvat
cocultur
macrophag
condit
medium
collect
studi
escherichia
coli
lp
sigmaaldrich
st
loui
mo
usa
ad
cocultur
system
ofsccmtreat
macrophag
final
concentr
ngml
transwel
cultur
system
macrophag
well
protein
analysi
flow
cytometri
well
experi
studi
without
lp
stimul
seed
pore
insert
transwel
bd
falcon
franklin
lake
nj
usa
cocultur
variou
number
ofsc
ratio
ofsc
number
versu
macrophag
number
transwel
system
adjust
period
cocultur
cell
incub
mix
medium
onehalf
dmemham
medium
macrophag
onehalf
imdm
contain
fetal
bovin
serum
ofsc
cocultur
hour
seri
experi
perform
macrophag
ofsc
respect
condit
medium
collect
variou
number
ofsc
ofscmacrophag
ratio
plate
sixwel
cultur
plate
condit
medium
collect
ofsc
starvat
macrophag
treat
mix
medium
onehalf
dmemham
medium
macrophag
onehalf
ofscscm
hour
ofsccm
treatment
studi
function
analysi
macrophag
perform
cell
cycl
analysi
cell
harvest
cell
scraper
wash
twice
fix
ethanol
nuclear
dna
stain
propidium
iodid
mg
ml
block
fc
receptor
minut
cd
isotypematch
control
antibodi
bd
bioscienc
san
jose
ca
usa
ad
incub
minut
dark
analyz
use
facscalibur
becton
dickinson
franklin
lake
nj
usa
flowjo
softwar
tree
star
ashland
usa
macrophag
harvest
resuspend
phosphatebuff
salin
cellular
suspens
mix
equal
amount
trypan
blue
solut
number
live
transpar
dead
blue
cell
count
use
hemacytomet
assist
sondheim
germani
cell
lysat
prepar
describ
previous
western
blot
analysi
perform
use
primari
antibodi
induc
nitric
oxid
synthas
ino
solubl
tumor
necrosi
factor
receptor
stnfr
type
ii
abcam
cambridg
usa
epitom
burlingam
ca
usa
densiti
protein
band
assess
use
comput
densitomet
imagepro
plu
softwar
media
cybernet
inc
bethesda
md
usa
total
rna
ofsc
macrophag
isol
use
trizol
invitrogen
carlsbad
ca
usa
revers
transcript
perform
use
mmlv
revers
transcriptas
invitrogen
one
microlit
revers
transcript
product
amplifi
use
primer
pair
specif
stnfr
type
ii
ido
gapdh
use
control
quantit
realtim
polymeras
chain
reaction
conduct
abi
prism
sequenc
detect
system
use
sybr
green
pcr
core
reagent
appli
biosystem
foster
citi
ca
usa
forward
revers
primer
amplif
present
tabl
primer
purchas
ambion
level
assay
follow
manufactur
protocol
sequenc
analysi
perform
ofsc
three
differ
donor
use
illumina
solexa
sequenc
total
read
gener
sampl
fastxtoolkit
use
trim
adapt
sequenc
remov
lowqual
read
use
identifi
mirna
express
mirna
normal
obtain
express
transcript
per
million
total
mirna
mirbas
detect
ofsc
mirna
select
highli
express
mirna
mirtar
appli
predict
interact
highli
express
mirna
gene
involv
secret
immunomodul
factor
msc
ido
hgf
stnfri
stnfrii
proinflammatori
cytokin
macrophag
respect
miranda
appli
analysi
mirnatarget
interact
gener
minim
free
energi
align
score
ofsc
transfect
inhibitor
dharmacon
bonn
germani
final
concentr
nm
use
sirna
transfect
reagent
signagen
laboratori
pittsburgh
pa
usa
accord
manufactur
instruct
level
ofsc
without
macrophag
cocultur
measur
realtim
revers
transcript
polymeras
chain
reaction
hour
inhibitor
transfect
put
target
gene
express
ofsc
evalu
cocultur
experi
male
balbc
mice
maintain
anim
facil
experiment
protocol
approv
anim
use
care
committe
taipei
medic
universitywan
fang
hospit
anim
model
lpsinduc
ali
establish
per
previou
report
briefli
lp
steril
salinemic
deliv
mice
biolasco
taiwan
co
ltd
taipei
taiwan
via
intratrach
inject
twenti
minut
lp
inject
ofsc
without
transfect
inhibitor
phosphatebuff
salin
administr
via
tail
vein
tail
vein
inject
phosphatebuff
salin
serv
control
anim
sacrif
hour
lp
exposur
lung
tissu
remov
stain
hematoxylin
eosin
condit
repeat
least
three
independ
mice
malondialdehyd
level
lung
tissu
detect
lipid
peroxid
mda
assay
kit
abcam
tissu
mg
homogen
ice
mda
lysi
buffer
abcam
centrifug
g
minut
remov
insolubl
materi
supernat
tba
solut
incub
minut
cool
room
temperatur
ice
bath
minut
absorb
nm
read
proport
malondialdehyd
level
valu
shown
mean
standard
error
mean
statist
analysi
perform
use
statist
packag
social
scienc
softwar
version
spss
inc
chicago
il
usa
data
comparison
perform
student
test
two
group
compar
p
oneway
analysi
varianc
analysi
follow
tukey
post
hoc
test
use
three
group
analyz
differ
characterist
repres
differ
level
signific
differ
consid
signific
confid
interv
previou
studi
lp
trigger
macrophag
infiltr
ofsc
inhibit
activ
tolllik
receptor
pathway
lung
parenchyma
present
studi
macrophag
treat
lp
variou
concentr
ngml
hour
lp
dosedepend
increas
express
ino
macrophag
figur
left
panel
ngml
lp
significantli
trigger
express
ino
product
macrophag
figur
right
panel
lp
concentr
ngml
thu
chosen
experi
determin
paracrin
potenc
ofsc
inhibit
ino
product
lpsactiv
macrophag
macrophag
treat
hour
condit
medium
collect
variou
number
ofsc
depend
ratio
ofsc
versu
macrophag
ofscmacrophag
ratio
ofscscm
dosedepend
decreas
ino
product
macrophag
induc
lp
figur
left
panel
ofscmacrophag
ratio
higher
significantli
inhibit
lpstrigger
ino
product
macrophag
figur
howev
neither
ngml
lp
figur
middl
ofsccm
ofscmacrophag
ratio
figur
right
alter
wellknown
marker
phenotyp
macrophag
first
hour
figur
left
studi
paracrin
effect
ofsc
macrophag
prolifer
number
macrophag
count
treatment
ofscscm
variou
concentr
hour
ofscmacrophag
ratio
higher
significantli
decreas
macrophag
number
lp
stimul
figur
flow
cytometri
cell
cycl
analysi
demonstr
ofscscm
noncontact
cultur
ofsc
increas
popul
macrophag
figur
quantit
analysi
regul
transit
western
blot
reveal
promot
factor
cyclin
macrophag
reduc
two
cdk
inhibitor
activ
ofscscm
figur
evalu
effect
ofsc
proinflammatori
capac
macrophag
macrophag
first
stimul
lp
serv
paramet
proinflammatori
cytokin
produc
lpsactiv
macrophag
shown
figur
neither
lp
ofscscm
alter
express
macrophag
figur
ofscscm
effect
inhibit
proinflammatori
abil
macrophag
first
hour
reduc
figur
figur
figur
express
trigger
lp
twentyfour
hour
later
protein
level
figur
figur
macrophag
also
reduc
ofscscm
ido
known
mscsecret
factor
regul
innat
immun
respons
procytokin
previou
vivo
studi
demonstr
system
ofsc
transplant
enhanc
serum
level
stnfr
type
ii
mice
lpsinduc
ali
present
studi
ofsc
express
immunomodul
factor
cocultur
macrophag
figur
furthermor
gene
express
figur
ido
figur
stnfr
type
ii
figur
figur
ofsc
highli
upregul
lpsactiv
macrophag
within
hour
noncontact
cultur
affect
upon
cocultur
figur
silenc
mainli
mirna
deepsequenc
analysi
mirtar
predict
perform
identifi
potenti
endogen
mirna
ofsc
msc
deriv
subcutan
tissu
well
msc
deriv
bone
marrow
target
induc
secret
immunomodul
factor
report
msc
ido
hepatocyt
growth
factor
stnfr
type
stnfr
type
ii
seven
mirna
found
potenti
regul
gene
target
predict
tabl
ofsc
express
level
transcript
per
million
low
act
regul
immunomodul
strongli
express
ofsc
transcript
per
million
target
one
gene
make
less
possibl
key
regul
studi
strong
express
level
transcript
per
million
ofsc
potenti
regul
gene
upregul
lpsactiv
macrophag
includ
stnfr
type
ii
figur
indic
may
key
mirna
ofsc
regul
induc
immunomodul
factor
procytokin
stimul
regul
ofsc
immunomodul
abil
target
stnfr
type
ii
determin
whether
ofsc
respons
activ
macrophag
compar
level
ofsc
normal
condit
noncontact
cultur
lpsactiv
macrophag
show
express
significantli
downregul
ofsc
cocultur
activ
macrophag
figur
furthermor
identifi
direct
target
transfect
inhibitor
ofsc
shown
figur
inhibitor
success
reduc
express
ofsc
normal
condit
cocultur
activ
macrophag
inhibit
ofsc
result
increas
mrna
level
stnfr
type
ii
ido
figur
notabl
bind
sequenc
stnfr
type
ii
figur
figur
demonstr
bind
affin
two
target
strong
evidenc
low
minim
free
energi
high
miranda
align
score
figur
ofsc
express
low
protein
level
stnfr
type
ii
protein
could
detect
ofsc
figur
howev
protein
level
stnfr
type
ii
ofsc
increas
inhibit
confirm
cytokin
level
respons
line
mrna
express
valu
figur
find
confirm
stnfr
type
ii
direct
target
final
ofsc
without
inhibitor
transfect
system
inject
mice
lpsinduc
ali
therapeut
effect
first
hour
compar
measur
malondialdehyd
level
readout
lipid
peroxid
indic
redox
statu
lung
result
show
redox
statu
lpsdamag
lung
parenchyma
significantli
reduc
ofsc
ofsc
preinhibit
figur
tissu
section
show
lp
trigger
inflammatori
cell
infiltr
interstiti
space
lung
parenchyma
increas
lung
permeabl
fluid
accumul
alveolar
space
figur
ofsc
transplant
amelior
lung
permeabl
inflammatori
first
hour
figur
moreov
less
cell
infiltr
larger
alveolar
space
note
ali
mice
receiv
ofsc
compar
mice
receiv
ofsc
figur
demonstr
preinhibit
ofsc
enhanc
antiinflamm
abil
lung
parenchyma
without
alter
antioxid
abil
ofsc
figur
first
report
endogen
particip
immunomodul
msc
directli
target
stnfr
type
ii
two
inhibitori
molecul
studi
find
lp
trigger
proinflammatori
abil
macrophag
figur
ofsc
inhibit
proinflammatori
activ
figur
induc
cell
cycl
arrest
figur
macrophag
paracrin
effect
lpsactiv
macrophag
excit
immunomodulatori
capac
ofsc
via
upregul
ido
stnfr
type
ii
figur
c
among
factor
stnfr
type
ii
ofsc
neg
regul
normal
condit
figur
rapidli
upregul
degrad
ofsc
trigger
activ
macrophag
figur
enhanc
antiinflammatori
abil
ofsc
figur
accord
data
condit
medium
ofsc
significantli
reduc
prolifer
proinflammatori
abil
macrophag
figur
immunomodulatori
abil
ofsc
could
induc
noncontact
cultur
lpsactiv
macrophag
figur
indic
paracrin
effect
ofsc
play
import
role
macrophag
regul
addit
therapeut
potenc
ofsc
attenu
macrophagemedi
inflamm
stronger
figur
induc
macrophag
cell
cycl
arrest
figur
known
number
ratio
msc
versu
immun
cell
critic
therapeut
effect
immunomodul
msc
regul
lymphocyt
msclymphocyt
ratio
natur
killer
cell
mscnatur
killer
cell
demonstr
ratio
ofsc
versu
macrophag
figur
initi
antiinflamm
ratio
initi
induct
macrophag
cell
cycl
arrest
figur
macrophag
may
initi
immun
reaction
releas
proinflammatori
cytokin
includ
macrophag
resid
tissu
polar
proinflammatori
macrophag
microenviron
exhibit
proinflammatori
activ
activ
thelper
type
lymphocyt
promot
thelper
type
respons
via
increas
phagocyt
activ
differ
bone
marrowderiv
msc
gingivaderiv
msc
ofsc
promot
gener
figur
significantli
reduc
proinflammatori
function
inhibit
figur
first
hour
indic
orbit
fatderiv
msc
regul
macrophag
target
rather
howev
exclud
possibl
polar
induct
ofsc
direct
cellcel
interact
longterm
paracrin
stimul
addit
measur
express
msc
deriv
differ
tissu
origin
data
show
strongli
express
ofsc
moder
express
msc
deriv
subcutan
fat
tissu
low
level
msc
deriv
bone
marrow
tabl
indic
regul
may
predominantli
exist
adipos
tissuederiv
msc
ido
secret
msc
particip
immun
toler
antiinflamm
could
stimul
proinflammatori
cytokin
data
lpsactiv
macrophag
enhanc
express
figur
c
ido
ofsc
respons
lpsactiv
macrophag
figur
addit
ido
stnfr
type
ii
ofsc
also
induc
activ
macrophag
figur
strong
inhibitor
proinflammatori
cytokin
chemokin
releas
activ
macrophag
colleagu
report
bone
marrowderiv
msc
reduc
mortal
improv
organ
function
experiment
cecal
ligationinduc
sepsi
directli
increas
product
lpsactiv
macrophag
accord
data
lpsactiv
macrophag
could
also
upregul
express
ofsc
figur
enhanc
may
justifi
effect
ofsc
suppress
macrophag
proinflammatori
cytokin
releas
natur
occur
cytokin
respons
physiolog
level
neutral
action
msc
releas
antagon
block
releas
activ
macrophag
two
critic
cytokin
initi
seri
inflammatori
respons
vivo
ilraexpress
msc
modul
inflammatori
respons
mice
bleomycininduc
lung
inflamm
fibrosi
addit
stnfr
type
stnfr
type
ii
inhibitori
solubl
molecul
found
bodi
fluid
well
tissu
reduc
toxic
effect
bodi
stnfr
type
ii
one
proteolyt
shed
solubl
extracellular
domain
tumor
necrosi
factor
receptor
secret
primarili
mononuclear
cell
administr
lp
human
msc
increas
concentr
stnfr
medium
suggest
solubl
receptor
may
part
neg
feedback
mechan
inhibit
biolog
effect
yagi
colleagu
report
therapeut
effect
intramuscular
inject
human
bone
marrowderiv
msc
endotoxem
anim
depend
secret
stnfr
type
previou
work
demonstr
system
ofsc
transplant
upregul
serum
level
stnfr
type
ii
stnfr
type
first
hour
intratrach
inject
lp
studi
demonstr
stnfr
type
ii
express
ofsc
consequ
respons
secret
lpsactiv
macrophag
figur
e
recent
mirna
identifi
critic
regul
immun
respons
lp
stimul
may
alter
express
mirna
macrophag
upregul
lpsactiv
macrophag
respons
interrupt
macrophag
differenti
tolllik
receptor
transcript
contrast
downregul
lpstreat
macrophag
inhibit
express
howev
disclos
msc
deriv
orbit
fat
tissu
play
role
regul
stnfr
type
ii
although
predict
interact
stnfr
type
ii
tabl
stnfr
type
ii
directli
inhibit
figur
c
reduct
ofsc
macrophagemedi
proinflammatori
environ
figur
result
upregul
stnfr
type
ii
ofsc
figur
e
contribut
antiinflamm
abil
ofsc
vivo
figur
ofsc
inhibit
macrophagemedi
inflamm
induc
macrophag
cell
cycl
arrest
paracrin
effect
activ
macrophag
trigger
immunomodul
factor
express
ofsc
ido
stnfr
type
ii
upregul
stnfr
type
ii
ofsc
cytokineinduc
fashion
initi
degrad
